Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

High-intensity physical exercise combined with melatonin supplements may offer more benefit to people with MS than either ...

Aspirin and acetaminophen may help ease MS fatigue, improve temperature regulation, and increase exercise capacity, a study ...

Supplementation with high-dose vitamin D for more than one year significantly reduced relapse risk and eased disability in ...